Colorectal cancer (CRC) is the third most common malignancy worldwide, with
approximately 50% of patients developing colorectal cancer liver metastasis (CRLM) during …

Simple Summary The treatment of peri-hilar (h-CCA) and intrahepatic (i-CCA)
cholangiocarcinoma is an evolving field in hepato-pancreato-biliary surgery. Continuous …

Cholangiocarcinoma is a deadly cancer comprising very heterogenous subtypes with a
limited therapeutic arsenal in all comers. However, recent significant advances were made …

Simple Summary Perihilar cholangiocarcinoma is a rare disease with generally poor
outcomes. Complete surgical resection remains the only chance at long-term survival …

Background Cholangiocarcinoma (CCA) is still a deadly tumour. Histological and molecular
aspects of thioacetamide (TAA)-induced intrahepatic CCA (iCCA) in rats mimic those of …

Background and aims Currently, there are still no definitive consensus in the treatment of
intrahepatic cholangiocarcinoma (iCCA). This study aimed to build a clinical decision …

Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are the most frequent
primary liver cancers, accounting for approximately 80% and 15%, respectively. HCC …

Simple Summary In the era of personalized oncology, next-generation sequencing plays an
important role in identifying mutations that may predict the molecular pathomechanism and …

Cholangiocarcinomas are a heterogeneous group of highly aggressive cancers that may
arise anywhere within the biliary tree. There is a wide geographical variation with regards to …

Cholangiocarcinoma (CCA) is a rare malignancy originating from the biliary tree and is
anatomically categorized as intrahepatic (iCCA), perihilar, and extrahepatic or distal. iCCA …